NCT06879912 A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
| NCT ID | NCT06879912 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intuitive Surgical |
| Condition | Hernia, Inguinal |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-05-22 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-05-22 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to understand the utility of force feedback instruments in surgeries that are done using the da Vinci 5 robot.
Eligibility Criteria
Pre-Operative Inclusion Criteria: 1. Age 22 years or older 2. ASA ≤ 3 3. The clinical decision has been made to perform multi-port robotic assisted surgery with da Vinci 5 with Force Feedback instruments for the study specified procedure as primary procedure prior to enrollment in the study 4. Subject or a legally authorized representative is able to provide written informed consent using the study informed consent form prior to the study 5. Subject is willing and able to comply with the study protocol requirements including follow up schedule Pre-operative Exclusion Criteria: * Subject receiving an emergent procedure * Subject planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned * Subject with previous ipsilateral surgery (open, endoscopic or robotic) with the same surgical indication * Subject with past or ongoing medical conditions (for example: inflammatory bowel disease) which, in the judgment of the Investigator, puts them at high risk for surgery and not appropriate for the study * Subject is pregnant or suspected to be pregnant or breastfeeding * Subject has any other condition or personal circumstance that, in the judgment of the Investigator, might interfere with the collection of complete quality data * Subject is currently participating in or has participated in a study of an investigational agent or a significant risk investigational device study within the past 6 months * Subject belongs to a vulnerable population. * Subject is contraindicated for anesthesia or surgery. * Subject has had previous neoadjuvant therapy, previous chemotherapy, immunotherapy, and/or radiation therapy for the treatment of the cancer to be resected within the past 6 months Intra-operative Exclusion Criteria * Subject with hemodynamic or respiratory instability, which precludes the Investigator from performing the RAS. * Subject in whom inadequate visualization makes a minimally invasive approach not feasible, as determined from the investigator assessment prior to docking the robot. * Subject with adhesions, scarring and disease status in the body which in the opinion of the investigator limits the ability to perform the minimally invasive procedure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06879912 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Hernia, Inguinal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06879912 currently recruiting?
Yes, NCT06879912 is actively recruiting participants. Contact the research team at smruthi.srinivasamurthy@intusurg.com for enrollment information.
Where is the NCT06879912 trial being conducted?
This trial is being conducted at Miami, United States, Gainesville, United States, Chicago, United States, Columbus, United States and 1 additional location.
Who is sponsoring the NCT06879912 clinical trial?
NCT06879912 is sponsored by Intuitive Surgical. The trial plans to enroll 200 participants.